Genscript Biotech Corporation
GNNSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,694 | $5,143 | $6,208 | $9,239 |
| - Cash | $132 | $1,446 | $1,024 | $1,181 |
| + Debt | $171 | $417 | $350 | $156 |
| Enterprise Value | $2,733 | $4,113 | $5,533 | $8,215 |
| Revenue | $594 | $840 | $626 | $511 |
| % Growth | -29.2% | 34.2% | 22.4% | – |
| Gross Profit | $272 | $410 | $304 | $283 |
| % Margin | 45.8% | 48.8% | 48.6% | 55.3% |
| EBITDA | $70 | -$249 | -$355 | -$466 |
| % Margin | 11.8% | -29.6% | -56.7% | -91.1% |
| Net Income | $2,962 | -$95 | -$227 | -$359 |
| % Margin | 498.2% | -11.4% | -36.3% | -70.2% |
| EPS Diluted | 1.36 | -0.045 | -0.11 | -0.18 |
| % Growth | 3,102.2% | 58.8% | 38.9% | – |
| Operating Cash Flow | $76 | -$287 | -$120 | -$137 |
| Capital Expenditures | -$148 | -$158 | -$204 | -$137 |
| Free Cash Flow | -$72 | -$445 | -$324 | -$274 |